Fisher Clare 4
4 · Gritstone bio, Inc. · Filed Jan 4, 2022
Insider Transaction Report
Form 4
Fisher Clare
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-01-01+38,000→ 38,000 totalExercise: $12.86Exp: 2031-12-31→ Common Stock (38,000 underlying)
Footnotes (1)
- [F1]The stock option shall vest and become fully exercisable with respect to 1/36th of the entire number of shares subject to the stock option on each monthly anniversary of the grant date over a 36 month period, so that the entire number of shares shall vest and become exercisable on January 1, 2025, subject to the Reporting Person's continuing status as a service provider through each monthly vesting date.